Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 for the Treatment of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in China Apr 8, 2020 Life Science
Healthcare Roundup – CytoDyn to supply leronlimab to UK COVID-19 patients, Global COVID-19 cases top 1.4M Apr 7, 2020 Life Science
Seneca Biopharma, Inc. Announces the Completion of Stem Cell Manufacturing Facility in China Apr 3, 2020 Life Science
Healthcare Roundup –Amarin jumps 18% on possible patent win, Global COVID-19 cases approaching 900K Apr 1, 2020 Life Science
Healthcare Roundup – FDA OKs emergency use of 2-minute coronavirus test, U.S. COVID-19 pandemic could peak late April Mar 31, 2020 Life Science
Alphamab Oncology Announces Clinical Supply Collaboration with Pfizer on KN026 in Combination with Ibrance(R) (palbociclib) Mar 30, 2020 Life Science
Healthcare Roundup –Trump says G-20 nations coordinating on Covid-19, TherapeuticsMD suspends guidance due to Covid-19 Mar 27, 2020 Life Science
AnPac Bio Granted Important Novel Micro Medical Device Patent in the United States Mar 25, 2020 Life Science
Healthcare Roundup – AbbVie and Allergan ink agreement, Qiagen to ramp up production of RNA extraction kits for coronavirus tests Mar 18, 2020 Life Science
Healthcare Roundup –Predictive Oncology up 50%，Neogen ramps up production of disinfectants to fight COVID-19 Mar 13, 2020 Life Science
Healthcare Roundup –Vir Biotech up 14% premarket on NIH coronavirus collaboration, RedHill Biopharma up 5% premarket on coronavirus plan Mar 11, 2020 Life Science
Japan’s Regulatory Agency, PMDA, Clears RepliCel Life Sciences to Proceed to Final Consultation for Tendon and Skin Cell Therapy Products Mar 11, 2020 Life Science
Japan’s Patent Office Issues RepliCel Two New Patents for its Regenerative Medicine Technologies Mar 10, 2020 Life Science
Healthcare Roundup – Coronavirus testing available in every state, PerkinElmer cuts views due to coronavirus outbreak Mar 10, 2020 Life Science
